More Albuminuria Measurement Needed in Primary Care "Measurement of albuminuria in people with type 2 diabetes is improving in Europe, but is not yet at the level that's needed," commented Dr ...

An SGLT2 inhibitor combined with a nonsteroidal mineralocorticoid receptor antagonist quickly cut urinary albumin-to-creatinine ratio (UACR) in patients with albuminuria and both chronic kidney ...

"BioCity’s SC0062 gains NMPA breakthrough therapy designation" was originally created and published by Pharmaceutical ...

Microcalcification activity was positively associated with the extent of albuminuria, and a trend remained after adjustment. Average myocardial flow reserve ...

Early albuminuria reduction with finerenone (Kerendia) drove protection against chronic kidney disease (CKD) progression in people with type 2 diabetes, according to a post-hoc mediation analysis.

BOSTON — Finerenone reduces CV and renal events in patients with type 2 diabetes and chronic kidney disease, and albuminuria is a good screening tool to identify candidates, according to a speaker.

When the study drugs were discontinued, albuminuria returned to near baseline. Any adverse event (AE) occurred in 52% of the trial population, and serious AEs in 6.1% to 7.1% across arms.

BioCity Biopharma ("BioCity") announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD ...

Early change in albuminuria with canagliflozin predicts kidney and cardiovascular outcomes: A posthoc analysis from the CREDENCE Trial. J Am Soc Nephrol. 2020;31(12):2925-2936.

In addition to 'Albuminuria', there may be other similar symptoms or signs that better match your side effect. These have also been listed below for your convenience.

Continues to anticipate announcing topline data from Explore-CKD trial in Q2 2025RADNOR, Pa., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage ...